When should collateral information be obtained, and what privacy considerations apply?

• A. Only at treatment start; ignore privacy.
• B. When patient cognitive or communicative ability is limited or safety concerns exist; obtain with patient consent and ensure privacy and data-sharing protocols.
• C. Never obtain collateral information.
• D. Requires court order.

Answer: (B)

Gathering collateral information while protecting privacy requires balancing the need for a complete clinical picture with patient confidentiality. Collateral information comes from people who know the patient well—family, friends, caregivers, teachers, or other professionals—and helps fill in gaps when the patient cannot fully report due to cognitive or communication limitations or when there are safety concerns that require a clearer assessment.

You should obtain collateral information when the patient’s ability to report is limited or when safety risks exist. This ensures you have enough context to assess risks, clarify diagnoses, and plan appropriate treatment. Always seek the patient’s consent to share information when possible, and involve a legally authorized representative if the patient cannot provide informed consent. Protect privacy by sharing only what is necessary, using secure methods, and following data-sharing policies and privacy laws. Document what information was shared, with whom, for what purpose, and the consent status.

This approach avoids relying on collateral information inappropriately, respects the patient’s rights, and recognizes that consent and privacy protections are integral to clinical decision-making. It’s not about obtaining collateral data only at the start, never sharing information, or requiring a court order every time—consent and privacy safeguards guide when and how this information is collected and shared.